» Authors » Aurelie Caillon

Aurelie Caillon

Explore the profile of Aurelie Caillon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 291
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
El Chemaly A, Jaquet V, Cambet Y, Caillon A, Cherpin O, Balafa A, et al.
Biochim Biophys Acta Mol Cell Res . 2023 Jan; 1870(3):119415. PMID: 36640925
The voltage-gated hydrogen channel Hv1 encoded in humans by the HVCN1 gene is a highly selective proton channel that allows large fluxes of protons across biological membranes. Hv1 form functional...
2.
Abdul F, Ribaux P, Caillon A, Malezieux-Picard A, Prendki V, Vernaz N, et al.
Viruses . 2022 Oct; 14(10). PMID: 36298674
Not all antibodies against SARS-CoV-2 inhibit viral entry, and hence, infection. Neutralizing antibodies are more likely to reflect real immunity; however, certain tests investigate protein/protein interaction rather than the fusion...
3.
Malezieux-Picard A, Abdul F, Herrmann F, Caillon A, Ribaux P, Cambet Y, et al.
Diagnostics (Basel) . 2022 Aug; 12(8). PMID: 36010162
Background: The SARS-CoV-2 pandemic was particularly devastating for elderly people, and the underlying mechanisms of the disease are still poorly understood. In this study, we investigated fusion inhibitory antibodies (fiAbs)...
4.
Preynat-Seauve O, Nguyen E, Westermaier Y, Heritier M, Tardy S, Cambet Y, et al.
Front Pharmacol . 2021 Aug; 12:664608. PMID: 34421588
Phenazopyridine is a widely used drug against urinary tract pain. The compound has also been shown to enhance neural differentiation of pluripotent stem cells. However, its mechanism of action is...
5.
Labyb M, Chretien C, Caillon A, Rohner-Jeanrenaud F, Altirriba J
Int J Mol Sci . 2018 Dec; 20(1). PMID: 30587816
Whereas leptin administration only has a negligible effect on the treatment of obesity, it has been demonstrated that its action can be improved by co-administration of leptin and one of...
6.
Pataky Z, Guessous I, Caillon A, Golay A, Rohner-Jeanrenaud F, Altirriba J
Int J Obes (Lond) . 2018 Jul; 43(5):1120-1124. PMID: 30006581
Exogenous oxytocin administration in obese mice, rats, and monkeys was shown to induce sustained weight loss, mostly due to a decrease in fat mass, accompanied by an improvement of glucose...
7.
Caillon A, Duszka K, Wahli W, Rohner-Jeanrenaud F, Altirriba J
Metabolism . 2018 Jun; 87:13-17. PMID: 29936173
Background: Oleoylethanolamide (OEA) is an endocannabinoid that controls food intake, energy expenditure and locomotor activity. Its anorexigenic effect appears to be mediated by PPARα, but the tissue where the presence...
8.
Poher A, Veyrat-Durebex C, Altirriba J, Montet X, Colin D, Caillon A, et al.
Diabetes . 2015 Jul; 64(11):3700-12. PMID: 26224884
Brown adipose tissue (BAT), characterized by the presence of uncoupling protein 1 (UCP1), has been described as metabolically active in humans. Lou/C rats, originating from the Wistar strain, are resistant...
9.
Peyrou M, Bourgoin L, Poher A, Altirriba J, Maeder C, Caillon A, et al.
J Hepatol . 2014 Sep; 62(2):421-9. PMID: 25234947
Background & Aims: PTEN is a dual lipid/protein phosphatase, downregulated in steatotic livers with obesity or HCV infection. Liver-specific PTEN knockout (LPTEN KO) mice develop steatosis, inflammation/fibrosis and hepatocellular carcinoma...
10.
Altirriba J, Poher A, Caillon A, Arsenijevic D, Veyrat-Durebex C, Lyautey J, et al.
Endocrinology . 2014 Aug; 155(11):4189-201. PMID: 25157455
Oxytocin has been suggested as a novel therapeutic against obesity, because it induces weight loss and improves glucose tolerance in diet-induced obese rodents. A recent clinical pilot study confirmed the...